Trial intelligence / Profile preview

Ziprasidone Cross Titration in Schizophrenia or Schizoaffective Disorder

NCT00649064Phase 4Completed

Sponsor
Viatris
Start
Dec 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ziprasidone in schizophrenia, schizoaffective disorder, sponsored by Viatris. Started Dec 2003; status: completed.

02

Drugs

ziprasidone
03

Conditions

schizophreniaschizoaffective disorder

Beyond the preview

Go deeper on NCT00649064.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00649064.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call